Get alerts when AEHR reports next quarter
Set up alerts — freeAehr Test shares rose 26.5% after the company raised its fiscal 2027 revenue outlook to $150 million, the top of its previous range, following record first-quarter revenue and strong bookings. The main caveat is that NAND opportunities are progressing more slowly than expected, while a major AI customer’s potential high-volume production decision remains contingent on evaluation.
See AEHR alongside your other holdings
Add to your portfolio — freeTrack Aehr Test Systems in your portfolio with real-time analytics, dividend tracking, and more.
View AEHR Analysis